Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease, predominantly of prematurely born infants, characterized in its severest from by extensive hemorrhagic inflammatory necrosis of the distal ileum and proximal colon. NEC affects thousands of newborns in the U.S.A. every year with death occurring in 10-50% of affected individuals (27, 32) . Survivors of a severe occurrence frequently suffer the effects of short bowel syndrome, resulting in prolonged medical expenses and chronic gastrointestinal difficulties (24, 25) . As more premature infants are born in this country each year (22) , the effects of this disease are likely to contribute to greater morbidity and mortality. The pathophysiology of this disease remains poorly understood; however prematurity, enteral feeding, intestinal hypoxia-ischemia, and bacterial colonization are considered major risk factors (4, 20, 39) . A better understanding of the mechanisms involved in the development of NEC and elucidation of early pathological changes in tissues at the molecular level will help to improve therapy and could lead to prevention of this disease.
The major risk factors for NEC likely promote an inflammatory cascade that results in the pathology associated with this disease. Of the many cytokines that play important roles in inflammation, pro-inflammatory IL-18 has been implicated in inflammatory diseases of the small intestine (23, 30, 34, 43) . IL-18 is capable of inducing interferon gamma (IFN-) alone, and together with interleukin 12 (IL-12) can work synergistically to induce greater quantities of IFN-. IL-18 is also capable of promoting an inflammatory cascade by enhancing the release of proinflammatory TNF-. TNF-, in turn, can stimulate production of IL-12. IL-18, IL-12 and Page 3 of 29 TNF-can also activate NF-B, which initiates transcription of a variety of pro-inflammatory genes.
We have previously shown that IL-18 is significantly increased in the ileum (16) and liver (15) of neonatal rats with NEC. Further, there is a positive correlation between production of IL-18 and the progression of ileal damage during disease development (16) . To determine if IL-18 contributes to intestinal pathology in experimental NEC, we subjected IL-18 -/-mice to the protocol currently utilized in our laboratory and others to develop NEC in neonatal ratsenteral feeding of newborn, never-suckled pups with cow's milk based formula coupled with twice daily exposure to asphyxia and cold stress (9, 12, 13, (15) (16) (17) . We evaluated the incidence and severity of disease as well as specific parameters known to be altered in experimental NEC:
pro-inflammatory cytokine production, infiltration of macrophages and I B-and I B-in the ileum and liver.
METHODS
Animal model. This protocol was approved by the Animal Care and Use Committee of the University of Arizona (A-324801-95081). Neonatal B6.129P2-Il18 tm1Aki /J (IL-18 -/-) and C57BL/6J (WT) mice were purchased from The Jackson Laboratory (Bar Harbor, ME).
Homozygous breeder pairs were utilized; IL-18-/-pups originating from 12 separate litters and WT mice originating from 10 separate litters were utilized in 3 different experiments. Newborn IL-18 -/-(NEC IL-18 -/-) and WT (NEC WT) mice were collected immediately after birth to prevent suckling of maternal milk. All pups were hand-fed 50 ul rat milk substitute every 3 hours for 3 days using the Hoshiba Nipple: Yajima style (19, 44) developed and manufactured by Meiji Dairies Corporation (Tokyo, Japan). Using this device (Figure 1 ), newborn mouse pups could be fed measured amounts of diet without potential physical damage inherent in the gavage method typically utilized in the much larger neonatal rat. All pups were stressed twice daily with asphyxia (breathing 100% nitrogen gas for 60 seconds) followed by cold (4 0 C for 5 minutes).
Three day-old dam-fed wild-type (DF WT, n = 10) and dam-fed IL-18 -/-(DF IL-18 -/-, n = 15) pups were used for comparison in all evaluations.
NEC Evaluation. Pathologic changes in intestinal architecture were evaluated using the NEC scoring system developed for use in neonatal rats. From each animal, 0.5 cm sections of tissue from the distal ileum, proximal and proximal colon were fixed overnight in 70% ethanol, paraffin-embedded, microtome-sectioned at 4-6 µm, and stained with hematoxylin and eosin for histological evaluation. Histological changes in the ileum were scored by a blinded evaluator on a scale of 0 (normal) to 4 (necrosis) using our previously publish ileal damage scoring scale in neonatal rats (12) (13) (14) (15) (16) (17) .
Immunohistology. Ethanol-fixed, paraffin-embedded liver and ileum were serialsectioned at 4-6 µm. After deparaffinizing, sections were blocked with 1.5% appropriate serum No immunostaining was observed in the immunostaining controls. Sections from both experimental groups were stained for a specific primary antibody at the same time so that comparisons between groups could be assessed. Stained slides were evaluated by a blinded observer and enumeration of positively stained cells was accomplished by counting ten 40X microscopic fields.
Western Blot: Individual frozen ileum or liver samples were homogenized with a handheld homogenizer (Pellet Pestle®, Kimble/Kontes, Vineland, NJ) in a 5x volume of ice-cold homogenization buffer (50 mM Tris HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 0.1% SDS; 1% Na-deoxycholic acid; 1% Triton X-100; 50 mM DTT; 50 µg/ml aprotinin; 50 µg/ml leupeptin; 5 mM PMSF). The homogenates were centrifuged at 10,000 rpm for 5 min at 4 C and the supernatant was collected. Total protein concentration was quantified using the Bradford protein overnight at 4 C. After being washed, the membranes were incubated for 1 hr at room temperature with the appropriate horseradish peroxidase-conjugated secondary antibody.
Proteins were visualized with a chemiluminescent system (Pierce, Rockford, IL) and exposed to x-ray film. Membranes were stripped and probed with anti--actin to determine equal loading of Statistics: Statistical analyses between groups were performed using ANOVA followed by Fisher PLSD. Analysis of NEC score was accomplished using the Mann-Whitney test for non-parametric values and the Chi-Square test was utilized to analyze differences incidence of disease. All statistical analyses were determined using the statistical program StatView (Abacus Concepts, Berkeley, CA). All numerical data are expressed as mean ± SEM. with numbers similar to those in both the DF WT and DF IL-18 -/-groups (Table 1, Figure 6 ).
RESULTS

Incidence and severity of NEC in IL-
NF-B in IL-18 -/-mice subjected to the NEC protocol. Activation of NF-B is a
hallmark of the inflammatory cascade and has been implicated in NEC pathogenesis. Because of the limited amount of ileal tissue obtainable from 3 day-old mouse pups, we did not have enough tissue to determine NF-B activation using nuclear extracts. NF-B is held inactive in the cell cytoplasm by the inhibitor protein I B. Stimuli such as TNF-or IL-18 induce selective I B phosphorylation, which is then ubiquitinylated and degraded. Activated NF-B is then free to migrate to the nucleus (7, 26, 38) . As activated NF-B levels increase in the nucleus, cytoplasmic I B-and I B-should decrease (11, 33, 40) . Therefore, we evaluated ileal and hepatic I B-and I B-levels using Western blot. Ileal I B-levels were significantly lower in NEC WT mice compared to NEC IL-18-/-, DF WT and DF IL-18-/-mice (Fig 7) , indicating greater activation of NF-kB in the NEC WT group. Liver I B-levels were similar in all groups (Fig 8) . Ileal I B-levels were significantly lower in NEC WT mice compared to NEC IL-18-/-, DF WT and DF IL-18-/-mice. However, I B-levels were extremely variable in the NEC WT group, thus, statistically significant differences were not achieved (Fig 9) . Hepatic I B-levels were significantly lower in NEC IL-18 -/-mice compared to the other groups (Fig. 10) .
Discussion
Our previous studies suggested that IL-18 plays an important role in the pathogenesis of experimental NEC (13, 16) . In the studies presented herein, we show that IL-18 is a crucial component in the development of NEC as IL-18 knockout mice have significantly lower incidence and severity of NEC than wild-type mice that are able to produce IL-18.
Our previous studies were conducted using the well-characterized neonatal rat model of NEC. In this model, NEC is developed in newborn rats by feeding milk-based formula coupled with exposure to hypoxia and cold stress. The major advantage of the neonatal rat NEC model is that many clinical and pathological changes are similar to those found in humans; the abdomen is distended, blood is detected in stool, and the ileum and proximal colon are the most affected parts of the intestine. In addition, the major risk factors for human NEC (intestinal immaturity, enteral formula feeding, and hypoxia/ischemia) are essential factors to develop disease in the rat model (4-6).
The main disadvantage of this model is the lack of knockout or genetically modified rat strains with which to investigate mechanisms of disease development and pathology. Currently, mechanistic evaluations in the rat model require inhibition of potential disease contributors with specific antibodies or specific chemical inhibitors. The paucity of congenic, knockout or spontaneous mutant rat strains has severely hampered research into this disease. Thus, the ability to utilize a neonatal mouse model of NEC increases the ability to investigate disease pathogenesis and the molecular mechanisms underlying these processes. By developing a mouse model of NEC that encompasses the major risk factors for human disease and applying this model to investigate the role of IL-18 in disease pathology, we are able to show that IL-18 is critical for disease development.
Inflammation requires a cascade of events and the up-regulation and activation of a number of pro-inflammatory mediators. Thus, some disease pathology would be expected even in the absence of a specific pro-inflammatory mediator such as IL-18. While disease development was not completely halted in NEC IL-18 -/-mice, our finding that the incidence of NEC was decreased from 61% to 12% in the NEC IL-18 -/-group offers proof that IL-18 is critical for disease pathology.
The complexities of inflammation are also illustrated in this model as some proinflammatory cytokines were decreased in NEC IL-18 -/-mice while others were unchanged.
The neonatal rodent intestine is immunologically immature. In fact, the majority of IL-18 in rat (16) and mouse (unpublished data) models of NEC is produced by intestinal epithelial cells rather than immune cells. We find essentially no TNF , IFN or IL-1 produced in the ileum during experimental NEC, but high levels of hepatic IL-1 and TNF (15) . Thus, the lack of decreased IL-1 and TNF in the ileum of NEC IL-18 -/-mice is likely a reflection of the small quantities of these cytokines found in the ileum during disease development rather than a direct consequence of the lack of IL-18. The parameters that are decreased in NEC IL-18 -/-micehepatic IL-1 and ileal macrophages -are parameters that are increased during experimental NEC. The only exception is hepatic TNF , which is increased in NEC but unchanged in IL-18 -/-mice subjected to the NEC protocol. While the reasons for this observation are unclear, it is not without prior precedent as Sakao et al. found elevated TNF levels in IL-18 -/-mice after LPS challenge (37) . They hypothesized that during sepsis, IL-18 can actually down-regulate TNF . It is possible therefore, that in the NEC IL-18 -/-group, the lack of IL-18 prevents downregulation of TNF , resulting in similar levels of hepatic TNF in all groups.
NF-B has been shown to play a role in intestinal inflammation in a number of models of colitis and IEC lines (21, 33, 35, 41, 42) . The importance of NF-B is underscored by the NF-B-induced expression of many cytokines, enzymes and adhesion molecules potentially involved in the pathogenesis of NEC. NF-B regulates transcription of and can be activated by a number of inflammatory mediators including TNF-, IL-18 and IL-12 (8, 18, 29) which we have shown to increased during NEC (13, 15, 16) . In addition, NOS2, a pro-inflammatory target gene of NF-B, is increased in intestinal inflammation (28, 36) and NEC (10, 31) and has been implicated in the pathogenesis of gut-barrier failure in IBD (1-3). Therefore, a crucial regulatory role of NF-B in the pathogenesis of NEC is likely. Using I B-and I B-as an indirect identifiers, our data suggest that there is a significant decrease in NF-B activation in IL-18-/-mice subjected to the NEC protocol. We speculate that hepatic TNF , which we have previously shown is the source of elevated TNF in the ileal luminal contents during NEC (12, 15) , may be responsible for both the activated ileal and hepatic NF-B.
In conclusion, we show that IL-18 is critical for the ileal pathology observed in experimental NEC. The results of these studies provide proof that IL-18 is crucial for disease development and suggest that neutralization of IL-18 could be utilized as a potential therapeutic approach to human NEC. 
